Publications by authors named "Aude Roy"

Claim this Profile
D
Development and Feasibility of a Mixed Virtual and in-Presence Therapeutic Education Program for Early Multiple System Atrophy Patients.
Margherita Fabbri, Estelle Harroch, Eva Camgrand, Paulo André Dias Bastos, Wassilios G Meissner, Aude Roy

Mov Disord Clin Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis.
Anne-Charlotte Le Floch, Caroline Imbert, Nicolas Boucherit, Laurent Gorvel, Stéphane Fattori, Aude Le Roy

Cancer Immunol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia.
Anne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, Amira Ben Amara, Marie-Sarah Rouviere, Aude Le Roy

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.
Stéphane Fattori, Aude Le Roy, Jemila Houacine, Lucie Robert, Riad Abes

Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer.
Stephane Fattori, Hugo Roux, Emilie Connen, Lucie Robert, Laurent Gorvel, Aude Le Roy

Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing.
Sumin Jo, Shipra Das, Alan Williams, Anne-Sophie Chretien, Thomas Pagliardini, Aude Le Roy

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
Aude Le Roy, Thomas Prébet, Rémy Castellano, Armelle Goubard, Florence Riccardi

Front Immunol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML.
Anne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy

Oncoimmunology· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.
Audrey Benyamine, Aude Le Roy, Emilie Mamessier, Julie Gertner-Dardenne, Céline Castanier

Oncoimmunology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
Magdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, Jacek Bil, Marta Siernicka, Aude Le Roy

MAbs· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity.
Anne-Sophie Chretien, Aude Le Roy, Norbert Vey, Thomas Prebet, Didier Blaise

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Q-switched Yb-doped nonlinear microstructured fiber laser for the emission of broadband spectrum.
Aude Roy, Mathieu Laroche, Philippe Roy, Philippe Leproux, Jean-Louis Auguste

Opt Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis